In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II StudyJoshua Brody, Ronald Levy, Weiyun Z. Ai et al.|Journal of Clinical Oncology|2010Cited by 487
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 studyYoun H. Kim, Ronald Levy, Dita Gratzinger et al.|Blood|2011Cited by 213
B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progressionJonathan M. Irish, Ronald Levy, June H. Myklebust et al.|Proceedings of the National Academy of Sciences|2010Cited by 168
High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cellsJune H. Myklebust, Ronald Levy, Jonathan M. Irish et al.|Blood|2013Cited by 154
Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cellsJonathan M. Irish, Ronald Levy, Debra K. Czerwinski et al.|Blood|2006Cited by 140